Change Country
Welcome to Luxembourg
Please read the important information below before continuing to our website

The Lyxor ETFs on this website may be restricted for certain individuals or in certain countries pursuant to the national regulations applicable to those individuals or countries. It is therefore your responsibility to ensure that you are authorised to invest in the Lyxor ETFs on this website. 

 

If you are an investor in the United Kingdom, please go to www.lyxoretf.co.uk  

If you are an investor in the Netherlands, please go to www.lyxoretf.nl  

If you are an investor in Italy, please go to www.lyxoretf.it  

If you are an investor in Spain, please go to www.lyxoretf.es  

If you are an investor in Austria, please go to www.lyxoretf.at  

If you are an investor in Germany, please go to www.lyxoretf.de   

If you are an investor in Singapore, please go to www.lyxoretf.com.sg  

If you are an investor in Switzerland, please go to www.lyxoretf.ch  

If you are an investor in Belgium, please go to www.lyxoretf.be  

If you are an investor in Poland, please go to www.lyxoretf.pl 

If you are an investor in Norway, please go to www.lyxoretf.no

If you are an investor in Denmark, please go to www.lyxoretf.dk

If you are an investor in Luxembourg, please go to www.lyxoretf.lu

If you are an investor in Sweden, please go to www.lyxoretf.se

If you are an investor in Finland, please go to www.lyxoretf.fi

 

 

The Lyxor ETFs on this website are undertakings for collective investment in transferable securities (UCITS) (i) domiciled in France and approved by the Autorité des Marchés Financiers (AMF) or, (ii) domiciled in Luxembourg, approved by the Commission de Surveillance du Secteur Financier (CSSF) and authorised to market their units or shares in the French Republic in accordance with the notification procedure under Article 93 of Directive 2009/65/EC. Investors should note that the prospectuses of certain Lyxor ETFs under Luxembourg law that have been notified in accordance with this procedure are only available on the website in English. A French translation of these prospectuses can be obtained upon request by sending a letter to Lyxor International Asset Management (“Lyxor”) – 17 Cours Valmy, 92987 Paris La Défense, France.

 

The information on this website is not intended for persons or entities that are resident, located or registered in jurisdictions that are not authorised to distribute Lyxor ETFs. As a result, the information on this website does not constitute an offer or solicitation to buy or sell units or shares in these ETFs by anyone in any jurisdiction:

 

(a)   in which such an offer or solicitation is unauthorised;

(b)   in which Lyxor is not qualified to make such an offer or solicitation; or 

(c)   in which it is unlawful to make such an offer or solicitation.

 

In particular, the Lyxor ETFs on this website are not and will not be registered under the United States Securities Act of 1933, as amended. As such, they may not be offered or sold within the United States of America, except in specific cases where transactions are exempt from registration under the Securities Act. The ETFs listed on this website may not be sold to US citizens or transferred to the United States by any other means, unless this transaction is not subject to any specific registration under US law. 

 

Any person from a jurisdiction to which the above-mentioned restrictions apply should inform themselves of and observe these restrictions.

 

This website is intended for commercial purposes and is not regulatory in nature. Although the information provided has been drawn up on the basis of sources considered to be reliable, there is no guarantee that it is accurate, complete or relevant. Some of the information on this website is provided on the basis of market data collected at a specific time and may therefore vary over time. Lyxor advises investors to read the risk factors section of the prospectus and the key investor information document carefully. These documents can be found on the website.

 

The net asset value (“NAV”) of Lyxor ETFs may at any time be subject to considerable price fluctuations, which in some cases may lead to the loss of all of the capital invested. Investors should note that some ETFs may be sensitive to fluctuations in the exchange rate between their reference currency and that of the underlying index, as well as of the components of the underlying index.

 

Before investing in a Lyxor ETF, you should carry out your own risk analysis of the product from a legal, tax and accounting perspective, rather than basing your decision solely on the information provided. If necessary, you should consult your own advisers or any other qualified professional. 

 

Subject to compliance with the legal obligations by which they are bound, Lyxor or any entity within the same group shall not be held liable for any financial or other consequences of an investment in the product. 

 

 

By clicking on institutional or individual above, I confirm that I have read and understood the information provided herein, and that I am resident or registered in Luxembourg.

 

By continuing to browse the site, you are agree on the use of cookies to track the number of visits.To know more about cookies policy:click here
31 Oct 2019

Notice to the shareholders of Multi Units Luxembourg

Notice to the shareholders of Multi Units Luxembourg

Amendment to the Prospectus and the Key Investor Information Document of the Sub-Funds
Terms not specifically defined herein shall have the same meaning as in the articles of incorporation and in the latest Prospectus of the Company or any supplement.
Luxembourg, the 31st October 2019
Dear Shareholders,
The Management Company and the Board of Directors of the Company, have decided of the changes detailed below in relation to the Sub-Funds (the “Changes”). The Changes relative to each Sub-Fund will be performed between the 2 December 2019 and the 30 April 2020 (the “Effective Date”). Once the Changes have been implemented on a Sub-Fund a notice will be published confirming the Effective Date.

I. Change of the Benchmark Indices

The aim of this change is to provide the Shareholders with an exposure to the New Benchmark Indices that
grant a broader exposure to their relevant underlying bond market.
The New Benchmark Indices are bond indices, calculated, maintained and published by Bloomberg
Barclays Indices.
A full description of the New Benchmark Indices and their construction methodology and information on the
composition and respective weightings of the New Benchmark Indices components are available on the
index provider's website at https://www.bloomberg.com/professional/product/indices/bloomberg-barclaysindices/
and in the Prospectus.
The attention of the Shareholders is drawn to the fact that the costs linked to this change of the
Benchmark Indices could have a negative impact on the net asset value of the Sub-Funds.


II. Change of the name of the Sub-Funds

The Sub-Funds will retain all their other characteristics, in particular the codes used in trading
and the total fees.
• In case where the Shareholders do not agree with these Changes, the Shareholders who usually
subscribe or redeem Shares in the Sub-Funds on the primary market may redeem their Shares
without fee during a period of one month as from the date of this notice.
• We draw Shareholders’ attention to the fact that if the Sub-Funds’ Shares are sold on a market
or exchange, the Shareholders may be charged broker fees on to the sale of (a) Share(s) in said
Sub-Funds.
• In case where the Shareholders agree with the Changes, no action is required from the
Shareholders.
Following the implementation of the Changes the Prospectus and the Key Investor Information Document
of the Sub-Funds will be amended accordingly.
The new Prospectus and Key Investor Information Document of the Sub-Funds may be obtained on request
from the Management Company to client-services-etf@lyxor.com, or consulted as from the Effective Date
on the following website: www.lyxoretf.com


For any questions, do not hesitate to contact Lyxor Client Services at the following contact details: Phone
number +33 (0)1 42 13 42 14 – Email address: client-services-etf@lyxor.com.
Yours sincerely,
For the Board of Directors